Zynext Ventures invests in MRI systems developer Promaxo
Promaxo’s magnetic resonance imaging (MRI) system is compatible with robotic procedures, enhancing precision in medical interventions.
Zydus Lifesciences‘ venture capital arm Zynext Ventures has announced a strategic investment in Promaxo, which develops low-field MRI systems. US-based Promaxo is also engaged in the development of minimally invasive robotics. This move is set to bolster advancements in point-of-care medical imaging and interventions with next-generation MRI systems.
